Carbohydrate antigen 19.9 accurately selects patients for laparoscopic assessment to determine resectability of pancreatic malignancy

Laparoscopy with laparoscopic ultrasonography (L-LUS) may be useful in the selection of patients for surgery to resect peripancreatic malignancy in addition to contrast-enhanced computed tomography (CE-CT). The present prospective study assessed the strategy of using carbohydrate antigen 19.9 (CA19....

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of surgery 2008-04, Vol.95 (4), p.453-459
Hauptverfasser:	HALLORAN, C. M, GHANEH, P, CONNOR, S, SUTTON, R, NEOPTOLEMOS, J. P, RARATY, M. G. T
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Biological and medical sciences CA-19-9 Antigen - metabolism Digestive system. Abdomen Endoscopy Female General aspects Humans Investigative techniques, diagnostic techniques (general aspects) Laparoscopy - methods Male Medical sciences Middle Aged Pancreatic Neoplasms - blood Pancreatic Neoplasms - diagnostic imaging Pancreatic Neoplasms - surgery Patient Selection Predictive Value of Tests Prospective Studies Ultrasonography, Interventional - methods
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!